HPV immunization coverage estimates among primary target cohort (9-14) in Portugal
Portugal: HPV immunization coverage estimates among primary target cohort (9-14) was 97.0% in 2025. ▬ Flat
Latest (2025)
97.0%
Change on year
unchanged
World rank
5th
of 111 countries
All-time high
97.0%
in 2024
All-time low
90.0%
in 2017
Years of data
16
2010–2025
HPV immunization coverage estimates among primary target cohort (9-14) in Portugal, 2010–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Portugal recorded 97.0% for hpv immunization coverage estimates among primary target cohort (9-14) in 2025. That is the highest value across all 16 years on record.
The figure is up 5.4% over ten years.
Over the whole period, hpv immunization coverage estimates among primary target cohort (9-14) in Portugal peaked at 97.0% in 2024 and was at its lowest, 90.0%, in 2017.
That places Portugal 5th out of 111 countries with data for 2025, putting it in the top 10%.
HPV immunization coverage estimates among primary target cohort (9-14) in Portugal, year by year
| Year | Value | Change |
|---|---|---|
| 2010 | 91.0% | — |
| 2011 | 92.0% | +1.1% |
| 2012 | 93.0% | +1.1% |
| 2013 | 94.0% | +1.1% |
| 2014 | 93.0% | -1.1% |
| 2015 | 92.0% | -1.1% |
| 2016 | 92.0% | +0.0% |
| 2017 | 90.0% | -2.2% |
| 2018 | 93.0% | +3.3% |
| 2019 | 93.0% | +0.0% |
| 2020 | 92.0% | -1.1% |
| 2021 | 92.0% | +0.0% |
| 2022 | 93.0% | +1.1% |
| 2023 | 93.0% | +0.0% |
| 2024 | 97.0% | +4.3% |
| 2025 | 97.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 92.3% | 90.0% | 94.0% | 10 |
| 2020s | 94.0% | 92.0% | 97.0% | 6 |
Countries ranked near Portugal
- 4 Bhutan 98.0% compare
- 5 Sao Tome and Principe 97.0% compare
- 7 Sri Lanka 96.0% compare
- 7 Lao People's Democratic Republic 96.0% compare
More health data for Portugal
- Un projection of annual infant deaths, annual growth rate -2.56 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.1616 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,112 deaths per 1,000 people (2090)
- Number of infants who die before age 1 38 deaths (2100)
- Population ages 60-64, female, annual growth rate 1.79 % change on previous year (2025)
- Population ages 60-64, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 60-64, female, per capita 0.0378 units per person (2025)
- Population ages 60-64, male, annual growth rate 1.44 % change on previous year (2025)
- Population ages 60-64, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 60-64, male, per capita 0.0326 units per person (2025)
Frequently asked questions
- What is hpv immunization coverage estimates among primary target cohort (9-14) in Portugal?
- Hpv immunization coverage estimates among primary target cohort (9-14) in Portugal was 97.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest hpv immunization coverage estimates among primary target cohort (9-14) recorded in Portugal?
- The highest recorded value was 97.0% in 2024.
- What is the lowest hpv immunization coverage estimates among primary target cohort (9-14) recorded in Portugal?
- The lowest recorded value was 90.0% in 2017.
- How does Portugal rank for hpv immunization coverage estimates among primary target cohort (9-14)?
- Portugal ranks 5th out of 111 countries with data for 2025.
- Is hpv immunization coverage estimates among primary target cohort (9-14) rising or falling in Portugal?
- Over the last ten years it is up 5.4%. The long-run trend across the full record is flat.
- Where does this Portugal data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of HPV immunization coverage estimates among primary target cohort (9-14 years old girls) (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 16 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).